According to reports in veterinary circles, science may, at last, be close to a major breakthrough in the treatment of laminitis in horses.
Better limb health for horses
In clinical trials, Laminil has been successful in stopping laminitis in 80 percent of horses treated so far and has shown efficacy with all types of laminitis.
Laminitis is inflammation of the hoof. Many triggers in a horse can lead to laminitis.This inflammation leads to destruction of the delicate laminae that connect the hoof wall to the coffin bone inside the hoof. The disease has ended the life of such great racehorses as Secretariat and Barbaro.
The drug Laminil is currently undergoing clinical trails, and full results should be available soon.
The active ingredient of Laminil is already FDA approved for humans, and it has been approved for investigational drug testing in horses. It is being tested in top veterinary facilities such as Dubai Equine Hospital in Dubai and Rood & Riddle Equine Hospital in Kentucky.
In the clinical trials, Laminil has been successful in stopping laminitis in 80 percent of horses treated so far. It has shown efficacy with all types of laminitis such as insulin resistance, equine metabolic syndrome, grain overload, grass founder, trauma and weight-bearing laminitis and no adverse effects have been noted.
Researchers are awaiting the full results of the horses that were treated, and say they will post more information as it becomes available.